Dr. Najjar is an assistant professor within the Division of Hematology/Oncology and recipient of numerous awards, including the 2019 junior scholar award for clinical cancer research related to novel immunotherapeutics in advanced melanoma. Dr. Delgoffe is an associate professor in the Department of Immunology, nationally recognized for his research pertaining to the metabolic contributions of T cell (dys)regulation. Together, Drs. Najjar and Delgoffe have identified metabolic targets and subsequent interventions that can improve anti-PD1 checkpoint blockade. We are thrilled to host these leaders in translational research. Please join us for their talk titled, “Targeting Tumor Cell Metabolism to Improve Treatment Outcomes in Metastatic Melanoma”.
May 17, 2022
“Targeting Tumor Cell Metabolism to Improve Treatment Outcomes in Metastatic Melanoma“
Greg Delgoffe, PhD
Associate Professor
Department of Immunology
University of Pittsburgh School of Medicine
Yana Najjar, MD
Assistant Professor of Medicine
Division of Hematology/Oncology
University of Pittsburgh School of Medicine
